Author: Mercy Heimbach
Durham-based biotech company fast tracks treatment aimed at COVID-19’s effects on younger patients
| CBS 17 News

DURHAM, N.C. (WNCN) – Durham-based Chimerix is on the fast track to saving lives of COVID-19 patients as experts learn more about deadly side effects for younger people. “We’ve essentially re-positioned the company to focus on getting this up and running in a matter of a few weeks,” said Chimerix CEO Mike Sherman. The drug DSTAT is […]

Durham Company Develops Drug That Could Help COVID-19 Patients
| Spectrum News

DURHAM, N.C. — The coronavirus attacks the body in so many ways, it has kept doctors guessing and sampling drugs they’ve used before for other purposes. Mike Sherman, the CEO of Chimerix, says it all started with a drug called DSTAT, under development to treat a serious and complicated type of cancer known as acute […]

OCD therapy sessions on the rise since coronavirus outbreak
| Fox 32 Chicago

Video: Stephen Smith, CEO of NOCD, talks about the increase of OCD therapy sessions since the outbreak of COVID-19 […]